| 1 |
31529265 | 68Ga-PSMA I&T PET/CT for primary staging of prostate cancer. | 2020 Jan |
2 |
| 2 |
30237214 | Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer. | 2019 Jan |
7 |
| 3 |
30514659 | Efficacy of early imaging with 68Ga-PSMA-I&T in the discrimination of pelvic lesions in prostate cancer patients. | 2019 Mar - Apr |
4 |
| 4 |
31069696 | The role of (68Ga)PSMA I&T in biochemical recurrence after radical prostatectomy: detection rate and the correlation between the level of PSA, Gleason score, and the SUVmax. | 2019 Aug |
1 |
| 5 |
30087939 | Effect of Carbohydration on the Theranostic Tracer PSMA I&T. | 2018 Jul 31 |
1 |
| 6 |
27635024 | Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer. | 2017 Feb |
6 |
| 7 |
27885457 | [PSMA-targeted radioligand therapy in prostate cancer]. | 2017 Jan |
1 |
| 8 |
28301262 | 213Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer Xenografts. | 2017 Mar |
2 |
| 9 |
28474140 | Comparison of PSMA-HBED and PSMA-I&T as diagnostic agents in prostate carcinoma. | 2017 Aug |
1 |
| 10 |
28511221 | [PSMA-Radioguided Surgery for Salvage Lymphadenectomy in Recurrent Prostate Cancer]. | 2017 Apr |
2 |
| 11 |
29324926 | Risk stratification and staging in prostate cancer with prostatic specific membrane antigen PET/CTObjective: A one-stop-shop. | 2017 Sep-Dec |
1 |
| 12 |
26964917 | Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer. | 2016 Aug |
1 |
| 13 |
27011373 | 68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging. | 2016 Dec |
1 |
| 14 |
27276206 | Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer. | 2016 Sep |
2 |
| 15 |
25883128 | Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy. | 2015 Jun |
3 |
| 16 |
26089548 | 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies. | 2015 Aug |
2 |
| 17 |
26608882 | [(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery. | 2015 Dec |
9 |
| 18 |
15153802 | Targeting prostate-specific membrane antigen in cancer therapy: can molecular medicine be brought to the surface? | 2004 Jun |
2 |